Andrew D Meyer, M.D., M.S., C.TS., FAAP

Federal

Funding Agency National Heart Lung and Blood Institute Title Contact Pathway Activation in Vascular Devices Status Active Period 7/2018 - 6/2023 Role Principal Investigator Grant Detail The goal of the project is to define the therapeutic potential of targeting contact activation to prevent vascular device-related thrombosis using in vitro, ex vivo and in vivo models of vascular devices. Funding Agency NIH Division of Loan Repayment 1st Renewal Title Platelet-derived microparticles generated by pediatric cardiopulmonary bypass As a novel biomarker of post-operative patient outcomes Status Active Period 7/2018 - 6/2020 Role Principal Investigator Grant Detail To reduce Dr. Meyer medical student loan debt to continue pediatric research Funding Agency DOD/CCCRP-Task Area: B-Coagulation & Blood Research @ USAISR Title Define optimal operating parameters for extracorporeal support in a clinically relevant in vitro ECMO model using human blood Status Active Period 10/2016 - 9/2019 Role Co-Investigator Grant Detail Combat Causality Research Program with Army Medicine. Accepted for funding but funds not available. Received a very competitive score of 1.9/5 Funding Agency DOD/CCCRP-Task Area: B-Coagulation & Blood Research @ USAISR Title Define the interaction of anti-coagulants and cell-based therapies with biomaterial surfaces in a laboratory ECMO model using human blood Status Active Period 10/2016 - 9/2019 Role Co-Investigator Grant Detail CCombat Causality Research Program with Army Medicine. Accepted for funding but funds not available. Received a very competitive score of 2.2/5 Funding Agency NIH/NHLBI Title Pro-thrombotic Microparticles Generated by Pediatric Cardiopulmonary Bypass Status Active Period 8/2015 - 4/2019 Role Principal Investigator Grant Detail The goal of this award is to provide the PI protected time and career development to define how pump-produced PMPs and MoMPs contribute to thrombosis, from a pediatric model of CPB and from pediatric patients supported by CPB, to understand the mechanisms and subsequent therapeutics to address extracorporeal blood pump related thrombotic complications. Funding Agency NIH Division of Loan Repayment Title Platelet-derived microparticles generated by pediatric cardiopulmonary bypass as a Novel biomarker of post-operative patient outcomes Status Complete Period 7/2016 - 6/2018 Role Co-Investigator Grant Detail To reduce Dr. Meyer medical student loan debt to continue pediatric research.

Private

Funding Agency STAGO Title Utility of ProCoag PPL in predicting thrombin generation and clot formation in CPB Status Complete Period 1/2017 - 12/2020 Role Principal Investigator Grant Detail The goal of this materials transfer agreement is to establish the clinical relevance of STAGO
Procoag PPL cloting test Funding Agency Jaeb Center for Health Research, INC. Title PREvelance of pediatric DIabetes CoagulopaThy (PREDICT STUDY) Status Active Period 4/2018 - 3/2020 Role Co-Principal Investigator Grant Detail To identify early markers for thromboembolism in diabetic-related cardiovascular and cerebrovascular mortality in T1DM and T2DM youth. Funding Agency Halyard Sales, LLC Title A randomized controlled trial for optimal feeding tube placement Status Active Period 12/2017 - 11/2019 Role Principal Investigator Grant Detail A randomized controlled trial for optimal feeding tube placement
Goal: To perform a randomized controlled trial to define if using Halyard Cortrak system compared to standard blind technique reduces time, complications, and radiographs associated with nasojejunal tube placement in pediatric patients. Funding Agency American Heart Association Title Coagulation Complications of Cardiopulmonary Bypass (C-3PO Study) Status Active Period 7/2016 - 6/2018 Role Principal Investigator Grant Detail The goal of this award is to define the generation and clearance of pro-thrombotic platelet-derived microparticles in adults and children supported with cardiopulmonary bypass.

State

Funding Agency School of Medicine Title Department of Pediatrics Faculty Start-Up Funds Status Active Period 9/2011 - 9/2018 Role Principal Investigator Grant Detail Allowed purchase of necessary equipment to establish the functionality of the research laboratory with both routine(e.g. refrigerator, pH meter, balance, pipettes) and specialized equipment (refrigerated centrifuge, -80 degree freezer, roller and centrifugal pumps), respectively

Funding Agency DOD/CCRP -Task Area B-Coagulation & Blood Research at USAISR Title Evaluation of the platelet protein, mRNA, and mitochondria DNA signatures generated in an in vitro model of ECMO using human blood Status Active Period 10/2016 - 9/2019 Role Co-Investigator Grant Detail Combat Causality Research Program with Army Medicine. Accepted for funding but funds not available. Received a very competitive score of 2.1/5 Funding Agency UTHSCSA CTSA-IIMS Title EMILIN2 genetic variation effects on platelet aggregation and thrombosis Status Complete Period 1/2016 - 9/2017 Role Principal Investigator Grant Detail The goal of this award is to define in the laboratory and in the clinic the overall hypothesis that EMILIN2 gene copy number will change the phenotype of platelet aggregation. Identification of this gene in humans will lead to new diagnostic and therapeutic interventions